BioSpace News Archive

Data presented at EADV demonstrate continued improvement in repigmentation of vitiligo lesions upon longer treatment duration with ruxolitinib cream

Concert Pharmaceuticals, Inc. presented results from its recently completed Phase 2 dose-ranging trial of the investigational medicine CTP-543 in patients with moderate-to-severe alopecia areata, an autoimmune disorder that results in patchy or complete hair loss.

Taltz is the first and only IL-17A inhibitor with published clinical trial results in pediatric patients with moderate to severe plaque psoriasis

Abrocitinib met all co-primary and secondary endpoints in JADE MONO-1 study

Topcon to Provide an Effortless Transition Path for Merge Eye Station™ and Merge Eye Care PACS™ Customers to Topcon Harmony & IMAGEnet 6 Data Management Platforms

UCI and RUCDR Infinite Biologics partner in establishing an important resource for translational medicine that is accessible to researchers worldwide.

In response to Gov. Gavin Newsom’s declared states of emergency in Los Angeles and Riverside Counties, Health Net, LLC is providing special assistance to ensure Health Net members affected by ongoing wildfires have access to essential prescription medications, critical Health Net information, and other healthcare services to help them cope with grief, loss, stress, or trauma.